Financial insights of DBD

MyFinsight

For the year ending 2025-12-31, DBD made $3,805,700K in revenue. $94,600K in net income. Net profit margin of 2.49%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-12-31	2024-12-31
Total revenues (note 17)	3,805,700	3,751,100
Service	1,648,500	-
Product	1,196,000	-
Total cost of sales	2,844,500	2,831,100
Gross profit	961,200	920,000
Selling and administrative expense	632,500	643,600
Research, development and engineering expense	86,700	93,600
Impairment of assets and other	0	-700
Total costs and expenses	719,200	737,900
Operating profit (loss)	242,000	182,100
Interest income	8,900	12,300
Interest expense	85,700	155,300
Foreign exchange gain (loss), net	-44,100	13,800
Reorganization items, net	0	-
Miscellaneous, net	4,000	1,500
Loss on extinguishment of debt	0	-7,100
Income (loss) before taxes	125,100	47,300
Income tax expense (benefit)	24,100	64,300
Equity in earnings (loss) of unconsolidated subsidiaries, net	-3,500	2,500
Net income (loss)	97,500	-14,500
Net income (loss) income attributable to noncontrolling interests	2,900	2,000
Net income (loss) attributable to diebold nixdorf	94,600	-16,500

Basic earnings (loss) per share (in dollars per share)	2.57	-0.44
Basic weighted-average shares outstanding (in shares)	36,800,000	37,600,000
Diluted earnings (loss) per share (in dollars per share)	2.54	-0.44
Diluted weighted-average shares outstanding (in shares)	37,200,000	37,600,000